Transchem Limited has filed an intimation with BSE Limited, dated July 31, 2026, under Regulation 30 read with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication pertains to the dispatch of physical letters to those members whose email addresses are not registered with the company, its Registrar and Share Transfer Agent, Depository Participants, or the Depositories. These letters provide the web-link and exact navigation path to access the Notice of the 49th Annual General Meeting and the Annual Report for Financial Year 2025-26.

49th Annual General Meeting Details

The 49th Annual General Meeting of Transchem Limited is scheduled to be held on Saturday, September 05, 2026, at 11:00 a.m. (IST). The meeting will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), in line with applicable regulatory provisions. The AGM notice and Annual Report for FY 2025-26 are being sent electronically to all shareholders whose email addresses are registered with the company, Depositories, or the Registrar and Transfer Agent (RTA).

For members whose email addresses are not on record, the company has provided the following access details:

The aforesaid documents are also available on the website of BSE Limited at www.bseindia.com .

SEBI Special Window for Physical Share Transfer Re-lodgement

Pursuant to a SEBI Circular dated January 30, 2026, a one-year special window has been opened from February 05, 2026, to February 04, 2027. This window allows investors to re-lodge physical share transfer deeds that were originally submitted before April 01, 2019, but were rejected or returned due to deficiencies. Eligible members are requested to rectify documentation issues and contact the company's RTA for assistance.

Shareholder Action Items

The company has requested shareholders to update their records as follows:

• Physical mode shareholders: Register or update email address, communication address, bank details, and nomination details by writing to the RTA at investor.helpdesk@in.mpms.mufg.com
• Dematerialized mode shareholders: Reach out to their respective Depository Participants at the earliest to update relevant details

The intimation was signed by Neeraja Karandikar, Company Secretary (ACS - 10130), on behalf of Transchem Limited. The company is registered at 111, Maker Chambers IV, 11th Floor, Nariman Point, Mumbai - 400021, with CIN: L66120MH1976PLC019327.

Transchem Limited reported a net profit of ₹429.51 lakh for the financial year ended March 31, 2026, down from ₹522.59 lakh in the prior year. The decline was driven by the absence of revenue from operations, as the company wound down its agricultural trading activities, and an increase in employee benefit expenses to ₹124.44 lakh from ₹67.00 lakh. Total income stood at ₹926.08 lakh, primarily derived from other income sources including interest on inter-corporate deposits and a capital gain from property sale. The Board has resolved not to recommend a dividend for FY26 to conserve resources for its strategic transition into the financial services sector.

The company’s 49th Annual General Meeting is scheduled for September 05, 2026, via video conferencing. Shareholders will consider the adoption of audited financial statements for FY26 and the re-appointment of Whole Time Director Mahesh Suresh Rananavre. Additionally, members are sought to approve material related party transactions with Crest Ventures Limited (CVL) for infrastructure and support services, capped at ₹5,00,000 over two financial years. The remote e-voting period runs from September 01, 2026, to September 04, 2026, with the book closure from August 30, 2026, to September 05, 2026.

Financial Performance Highlights

The following table summarizes the key financial metrics for FY26 compared to FY25:

Total comprehensive income rose to ₹426.18 lakh from ₹366.94 lakh, aided by lower other comprehensive income losses. Current liabilities increased significantly to ₹399.67 lakh from ₹30.11 lakh, largely due to advances received against the sale of investments in process. Cash and cash equivalents remained stable at ₹4,242.91 lakh.

Strategic Transition and Capital Raise

Transchem is undergoing a significant business model shift from natural and pharmaceutical products to financial services, including stockbroking and portfolio management. Shareholders previously approved amendments to the Memorandum of Association and an increase in authorized share capital to ₹7,500 lakh. The company has proposed a preferential issue of up to 6.15 crore warrants at ₹75 per warrant, aggregating to ₹46,125 lakh, to identified non-promoter investors. This issuance awaits in-principle approval from BSE Limited. Furthermore, the Board has granted in-principle approval for the acquisition of 100% equity in Greshma Shares & Stocks Limited, subject to regulatory clearances from SEBI and stock exchanges.

What the Numbers Show

The divergence between total income and net profit highlights the company's transitional state. With zero revenue from core operations, profitability is sustained by investment income and one-time gains, such as the ₹156.58 lakh gain on the sale of immovable property. The rise in other expenses to ₹239.91 lakh, driven by professional fees and regulatory filing costs associated with the corporate restructuring, underscores the upfront capital intensity of this strategic pivot before any new revenue streams commence.